Rika Aoyama, Hinano Nishikubo, Kyoka Kawabata, Saki Kanei, Yurie Yamamoto, Sadaaki Nishimura, Masakazu Yashiro. Clinical Significance of Multi-Cancer Genome Profiling: Data from a Single Hospital in Japan. Cancer genomics & proteomics. 2024. 21. 1. 79-87
Gen Tsujio, Masakazu Yashiro, Takashi Sakuma, Rika Aoyama, Koji Maruo, Yurie Yamamoto, Kiyoshi Maeda. Impact of SMAD2 and MET Expression on Lymph Node Metastasis of HER2-positive Gastric Cancer Cells. Anticancer research. 2023. 43. 10. 4359-4364
Yurie Yamamoto, Go Masuda, Shuhei Kushiyama, Koji Maruo, Gen Tsujio, Tomohiro Sera, Atsushi Sugimoto, Sadaaki Nishimura, Kenji Kuroda, Shingo Togano, et al. Establishment of a gastric cancer cell line with high microsatellite instability, OCUM-13, derived from Borrmann type-2 primary tumor. Cancer medicine. 2023. 12. 5. 6016-6022
Ryuichi Ito, Masakazu Yashiro, Takuma Tsukioka, Nobuhiro Izumi, Hiroaki Komatsu, Hidetoshi Inoue, Yurie Yamamoto, Noritoshi Nishiyama. GLUT1 and PKM2 may be useful prognostic predictors in patients with non-small cell lung cancer following curative R0 resection. Oncology letters. 2023. 25. 3. 129-129
Yurie Yamamoto, Hiroaki Kasashima, Yasuhiro Fukui, Gen Tsujio, Masakazu Yashiro, Kiyoshi Maeda. The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment. Cancer science. 2023. 114. 1. 16-24
